Predictive Oncology Inc./$POAI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Predictive Oncology Inc.
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.
Ticker
$POAI
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
24
ISIN
US74039M3097
Website
POAI Metrics
BasicAdvanced
$8.8M
-
-$1.75
-
-
Price and volume
Market cap
$8.8M
52-week high
$2.60
52-week low
$0.85
Average daily volume
191K
Financial strength
Current ratio
0.756
Quick ratio
0.683
Long term debt to equity
-963.678
Total debt to equity
-1,315.732
Management effectiveness
Return on assets (TTM)
-73.20%
Return on equity (TTM)
-490.37%
Valuation
Price to revenue (TTM)
3.528
Price to book
-59.71
Price to tangible book (TTM)
-44.57
Price to free cash flow (TTM)
-0.656
Growth
Revenue change (TTM)
24.17%
Earnings per share change (TTM)
-52.24%
3-year revenue growth (CAGR)
5.93%
3-year earnings per share growth (CAGR)
-34.25%
POAI News
AllArticlesVideos
AI Meets Genomics: Predictive Oncology Breakthrough Coincides with Regeneron's $256M 23andMe Acquisition
GlobeNewsWire·1 day ago
Predictive Oncology Inc. Issues Shareholder Letter Titled, "Revolutionizing Medicine: AI-Driven Biomarker and Drug Discovery for Precision Health"
GlobeNewsWire·3 days ago
Predictive Oncology Reports Year-End 2024 Financial Results and Provides Corporate Update
GlobeNewsWire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Predictive Oncology Inc. stock?
Predictive Oncology Inc. (POAI) has a market cap of $8.8M as of May 23, 2025.
What is the P/E ratio for Predictive Oncology Inc. stock?
The price to earnings (P/E) ratio for Predictive Oncology Inc. (POAI) stock is 0 as of May 23, 2025.
Does Predictive Oncology Inc. stock pay dividends?
No, Predictive Oncology Inc. (POAI) stock does not pay dividends to its shareholders as of May 23, 2025.
When is the next Predictive Oncology Inc. dividend payment date?
Predictive Oncology Inc. (POAI) stock does not pay dividends to its shareholders.
What is the beta indicator for Predictive Oncology Inc.?
Predictive Oncology Inc. (POAI) does not currently have a Beta indicator.